174 related articles for article (PubMed ID: 19438932)
21. RNA recognition motif of LEMD3 as a key player in the pathogenesis of Buschke-Ollendorff syndrome.
Takashima S; Fujita Y; Suzuki S; Saito N; Shinkuma S; Nomura T; Shimizu H
J Dermatol Sci; 2016 Mar; 81(3):205-8. PubMed ID: 26711937
[No Abstract] [Full Text] [Related]
22. Identification of a Novel Point Mutation in the LEMD3 Gene in an Infant With Buschke-Ollendorff Syndrome.
Kratzsch J; Mitter D; Ziemer M; Kohlhase J; Voth H
JAMA Dermatol; 2016 Jul; 152(7):844-5. PubMed ID: 27007781
[No Abstract] [Full Text] [Related]
23. Mutation in LEMD3 (Man1) Associated with Osteopoikilosis and Late-Onset Generalized Morphea: A New Buschke-Ollendorf Syndrome Variant.
Korman B; Wei J; Laumann A; Ferguson P; Varga J
Case Rep Dermatol Med; 2016; 2016():2483041. PubMed ID: 27382493
[TBL] [Abstract][Full Text] [Related]
24. [A twelve-year-old teenager with bone pain and white papules].
Champion V; Gérard M; Reinert P; Soria I
Arch Pediatr; 2005 Jul; 12(7):1124-8. PubMed ID: 15964529
[TBL] [Abstract][Full Text] [Related]
25. Buschke-Ollendorff syndrome due to a novel LEMD3 mutation - an unusual case of alopecia.
Darr-Foit S; Schliemann S; Schulz S; Elsner P
J Dtsch Dermatol Ges; 2018 Mar; 16(3):348-349. PubMed ID: 29465813
[No Abstract] [Full Text] [Related]
26. Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.
Whyte MP; Griffith M; Trani L; Mumm S; Gottesman GS; McAlister WH; Krysiak K; Lesurf R; Skidmore ZL; Campbell KM; Rosman IS; Bayliss S; Bijanki VN; Nenninger A; Van Tine BA; Griffith OL; Mardis ER
Bone; 2017 Aug; 101():145-155. PubMed ID: 28434888
[TBL] [Abstract][Full Text] [Related]
27. [Buschke-Ollendorff syndrome. Connective tissue nevi in osteopoikilosis].
Bonde CT; Vielfreund L
Ugeskr Laeger; 2001 Jan; 163(2):170-1. PubMed ID: 11379244
[TBL] [Abstract][Full Text] [Related]
28. Melorheostosis in a family with autosomal dominant osteopoikilosis.
Nevin NC; Thomas PS; Davis RI; Cowie GH
Am J Med Genet; 1999 Feb; 82(5):409-14. PubMed ID: 10069713
[TBL] [Abstract][Full Text] [Related]
29. Buschke-Ollendorff syndrome: a manifestation of a heterozygous nonsense mutation in the LEMD3 gene.
Gass JK; Hellemans J; Mortier G; Griffiths M; Burrows NP
J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S103-4. PubMed ID: 18489034
[No Abstract] [Full Text] [Related]
30. Depressed indurated plaque with elastorrhexis as a distinctive lesion in Buschke-Ollendorff syndrome.
Velasco Huici R; Martín JM; Vázquez B; Silva E; Estébanez A; Cuesta A; Ramón D; Monteagudo C
Pediatr Dermatol; 2020 Mar; 37(2):385-387. PubMed ID: 31943321
[TBL] [Abstract][Full Text] [Related]
31. Melorheostosis in a patient with familial osteopoikilosis.
Butkus CE; Michels VV; Lindor NM; Cooney WP
Am J Med Genet; 1997 Oct; 72(1):43-6. PubMed ID: 9295073
[TBL] [Abstract][Full Text] [Related]
32. Buschke-Ollendorff syndrome associated with hypertrophic scar formation: a possible role for LEMD3 mutation.
Korekawa A; Nakano H; Toyomaki Y; Takiyoshi N; Rokunohe D; Akasaka E; Nakajima K; Sawamura D
Br J Dermatol; 2012 Apr; 166(4):900-3. PubMed ID: 21985280
[No Abstract] [Full Text] [Related]
33. Papular elastorrhexis and Buschke-Ollendorff syndrome are different entities.
Cañueto J; Román C; Santos-Briz Á; Ciria S; González R; Unamuno P
J Am Acad Dermatol; 2011 Jul; 65(1):e7-9. PubMed ID: 21679808
[No Abstract] [Full Text] [Related]
34. Papular elastorrhexis: a variant of dermatofibrosis lenticularis disseminata (Buschke-Ollendorff syndrome)?
Schirren H; Schirren CG; Stolz W; Kind P; Plewig G
Dermatology; 1994; 189(4):368-72. PubMed ID: 7873822
[TBL] [Abstract][Full Text] [Related]
35. Modeling-based bone formation transforms trabeculae to cortical bone in the sclerotic areas in Buschke-Ollendorff syndrome. A case study of two females with LEMD3 variants.
Frost M; Rahbek ET; Ejersted C; Høilund-Carlsen PF; Bygum A; Thomsen JS; Andreasen CM; Andersen TL; Frederiksen AL
Bone; 2020 Jun; 135():115313. PubMed ID: 32151766
[TBL] [Abstract][Full Text] [Related]
36. Ossifying fibroma in Buschke-Ollendorff syndrome.
Dawson AL; Schulman JM; Jordan RC; North JP
J Cutan Pathol; 2014 Sep; 41(9):740-4. PubMed ID: 24917176
[TBL] [Abstract][Full Text] [Related]
37. [Buschke-Ollendorff syndrome: inactivating mutation of the LEMD3 gene].
Dereure O
Ann Dermatol Venereol; 2005; 132(6-7 Pt 1):593. PubMed ID: 16142115
[No Abstract] [Full Text] [Related]
38. Novel 4-bp Intronic Deletion (c.1560+5_1560+8del) [corrected] in LEMD3 in a Korean Patient With Osteopoikilosis.
Yoo IY; Song JS; Ki CS; Kim JW; Cha HS; Min YK
Ann Lab Med; 2017 Nov; 37(6):540-543. PubMed ID: 28840995
[TBL] [Abstract][Full Text] [Related]
39. Buschke-Ollendorff syndrome--differential diagnosis of disseminated connective tissue lesions.
Assmann A; Mandt N; Geilen CC; Blume-Peytavi U
Eur J Dermatol; 2001; 11(6):576-9. PubMed ID: 11701413
[TBL] [Abstract][Full Text] [Related]
40. Melorheostosis in a family with autosomal dominant osteopoikilosis: report of a third family.
Debeer P; Pykels E; Lammens J; Devriendt K; Fryns JP
Am J Med Genet A; 2003 Jun; 119A(2):188-93. PubMed ID: 12749062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
